highly significantP < .01
201 , 202 , 203 , 326 In the largest study to date, a randomized trial in 1050 CVCs and arterial catheters placed in a university hospital ICU, cutaneous antisepsis with 1% tincture of chlorhexidine showed a highly significant reduction in IVD-related BSIs compared with an iodophor (RR = 0.35, P < .01). 326 More recently, a meta-analysis that examined results from eight of the nine aforementioned studies found that use of chlorhexidine was associated with a nearly 50% reduction in the risk of IVD-related compared with povidone-iodine (RR = 0.49, 95% CI = 0.28 to 0.88). 201 Insertion Site Care and IVD Maintenance 1.